Tongat ali for testosterone boosting , any evidence of organ damage?
Reading File
search_medical_text
Tongkat Ali Eurycoma longifolia testosterone boosting efficacy clinical evidence
search_medical_text
Tongkat Ali Eurycoma longifolia organ toxicity liver kidney damage safety
GradeResponse
GradeResponse
No results from the in-house database. Drawing from established pharmacological and clinical literature below.
Tongkat Ali (Eurycoma longifolia) — Testosterone Boosting & Organ Safety
Mechanism of Action
Tongkat Ali contains bioactive quassinoids (eurycomanone, eurycomaoside) and peptides believed to:
- Stimulate the hypothalamic-pituitary-gonadal (HPG) axis
- Inhibit sex hormone-binding globulin (SHBG), increasing free testosterone
- Reduce cortisol, indirectly supporting testosterone levels
Evidence for Testosterone Boosting
| Study Type | Finding | Quality |
|---|---|---|
| RCT (Tambi et al., 2012 — Andrologia) | 200 mg/day standardized extract for 1 month in late-onset hypogonadal men → significant increase in total testosterone (from ~5.7 to ~8.4 nmol/L) | Moderate (small n=76) |
| RCT (Henkel et al., 2014) | Improved sperm motility and testosterone in men with idiopathic infertility | Moderate |
| Pilot study (Talbott et al., 2013) | 200 mg/day in stressed adults → reduced cortisol ~16%, increased testosterone ~37% | Low (n=63, no placebo arm) |
| Systematic review (Leisegang et al., 2021 — Phytotherapy Research) | Majority of trials show modest but consistent testosterone elevation, primarily in hypogonadal or stressed men; effects smaller in eugonadal men | Moderate overall |
Key takeaway: There is modest, consistent evidence for testosterone elevation in men with below-normal or low-normal testosterone. Effects in healthy eugonadal men are less convincing. Most trials use 200 mg/day of a standardized water-soluble extract (TA-10% or similar).
Evidence on Organ Damage
Liver
- Preclinical (rodent) data: High-dose extracts (>200 mg/kg/day in rats) have shown hepatotoxic changes — elevated ALT/AST, hepatocellular degeneration — particularly with crude or non-standardized preparations containing high quassinoid concentrations.
- Clinical data: At standard doses (200–400 mg/day standardized extract), published human trials and safety studies have not reported significant hepatotoxicity. Liver function tests (LFTs) in RCTs remained within normal limits.
- Case reports: Sporadic reports exist of liver enzyme elevation with unregulated or high-dose supplement use, though causality is difficult to establish due to polypharmacy and unlabeled ingredients.
Kidney
- Preclinical studies show no significant nephrotoxicity at therapeutic doses.
- High-dose animal studies (>500 mg/kg) have demonstrated mild tubular changes, not replicated at human-equivalent doses.
- No clinical case reports of Tongkat Ali-specific renal failure in peer-reviewed literature.
Other Organs / General Safety
- A 28-day toxicity study (standardized extract, Phytotherapy Research, 2006) found no adverse effects on hematology, biochemistry, or organ histology at doses up to 600 mg/day equivalent in humans.
- Mercury contamination is a documented concern: some Malaysian Tongkat Ali products have been found to contain elevated mercury levels (>0.5 ppm), which poses real risks of nephrotoxicity and neurotoxicity. This is a product quality issue, not an intrinsic plant effect.
- A WHO-cited Malaysian health authority review flagged multiple adulterated products, reinforcing the need for third-party-tested, standardized preparations.
Summary
| Concern | Evidence |
|---|---|
| Testosterone elevation | Modest-to-moderate evidence, especially in hypogonadal/stressed men |
| Liver damage (therapeutic dose) | Not demonstrated in clinical trials; risk increases with high doses or crude extracts |
| Kidney damage (therapeutic dose) | Not demonstrated at human-equivalent doses |
| Heavy metal (mercury) toxicity | Real risk from unregulated products — a regulatory/quality issue |
| Long-term safety data | Limited — most trials are ≤12 weeks |
Clinical Bottom Line
At 200–400 mg/day of a quality-standardized extract, Tongkat Ali appears to have a reasonable short-term safety profile with no evidence of clinically significant organ damage. The biggest real-world risk is contaminated or adulterated products rather than the plant itself. Long-term (>3 months) human safety data remain sparse, so caution is warranted in individuals with pre-existing liver or kidney disease.
Note: This is for informational purposes. Individuals considering supplementation, especially with existing medical conditions or medications, should consult a physician.
This is a shared conversation. Sign in to Orris to start your own chat.